BR0010249A - Processo para a preservação de vìrus e micoplasma - Google Patents

Processo para a preservação de vìrus e micoplasma

Info

Publication number
BR0010249A
BR0010249A BR0010249-0A BR0010249A BR0010249A BR 0010249 A BR0010249 A BR 0010249A BR 0010249 A BR0010249 A BR 0010249A BR 0010249 A BR0010249 A BR 0010249A
Authority
BR
Brazil
Prior art keywords
mycoplasma
virus
preservation
preserved
viruses
Prior art date
Application number
BR0010249-0A
Other languages
English (en)
Inventor
Eric Edward Worrall
Original Assignee
Eric Edward Worrall
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9909999.6A external-priority patent/GB9909999D0/en
Priority claimed from GBGB9926698.3A external-priority patent/GB9926698D0/en
Application filed by Eric Edward Worrall filed Critical Eric Edward Worrall
Publication of BR0010249A publication Critical patent/BR0010249A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18451—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/87—Mycoplasma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Patente de Invenção: "PROCESSO PARA A PRESERVAçãO DE VìRUS E MICOPLASMA". Um material biologicamente ativo compreendendo um vírus vivo ou micoplasma é preservado através de um processo de dessecação, sem liofilização, em uma matriz de trealose vítrea tendo um teor de umidade residual não maior que 2%. O processo compreende dois estágios de secagem à vácuo. Em um tempo de ciclo muito menor que um processo de secagem de congelamento típico um vírus ou micoplasma pode ser preservado para prover um material que pode ser reidratado para render uma vacina tendo potência.
BR0010249-0A 1999-05-04 2000-05-03 Processo para a preservação de vìrus e micoplasma BR0010249A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9909999.6A GB9909999D0 (en) 1999-05-04 1999-05-04 Protection of sensitive viruses and bacteria in vaccines
GBGB9926698.3A GB9926698D0 (en) 1999-11-12 1999-11-12 Method for the preserving of viruses, bacteria and biomolecules
PCT/GB2000/001524 WO2000066710A2 (en) 1999-05-04 2000-05-03 Method for the preservation of viruses and mycoplasma

Publications (1)

Publication Number Publication Date
BR0010249A true BR0010249A (pt) 2002-02-13

Family

ID=26315490

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010249-0A BR0010249A (pt) 1999-05-04 2000-05-03 Processo para a preservação de vìrus e micoplasma

Country Status (18)

Country Link
US (1) US6664099B1 (pt)
EP (1) EP1175486B1 (pt)
JP (1) JP2002542815A (pt)
KR (1) KR100616195B1 (pt)
CN (1) CN1433465A (pt)
AP (1) AP1521A (pt)
AT (1) ATE366797T1 (pt)
AU (1) AU776982B2 (pt)
BR (1) BR0010249A (pt)
CA (1) CA2365277A1 (pt)
DE (1) DE60035497T2 (pt)
DK (1) DK1175486T3 (pt)
EA (1) EA004131B1 (pt)
ES (1) ES2290028T3 (pt)
MX (1) MXPA01011145A (pt)
OA (1) OA11936A (pt)
TR (1) TR200103149T2 (pt)
WO (1) WO2000066710A2 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7569342B2 (en) 1997-12-10 2009-08-04 Sierra Molecular Corp. Removal of molecular assay interferences
SE0301436D0 (sv) * 2003-05-16 2003-05-16 Joakim Westberg New proteins
AU2005245338B2 (en) 2004-04-08 2011-11-17 Biomatrica, Inc. Integration of sample storage and sample management for life science
ES2470340T3 (es) 2005-12-28 2014-06-23 Advanced Bionutrition Corporation Vehículo de administración para bacterias probi�ticas que comprende una matriz seca de polisac�ridos, sac�ridos y polioles en forma vítrea
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
WO2008076975A1 (en) * 2006-12-18 2008-06-26 Advanced Bionutrition Corporation A dry food product containing live probiotic
SI2144998T1 (sl) 2007-04-06 2017-05-31 Takeda Vaccines, Inc. Postopki in sestavki za žive atenuirane viruse
CN105147611A (zh) * 2007-07-26 2015-12-16 圣诺菲·帕斯图尔有限公司 抗原佐剂组合物及其方法
DE102007036695A1 (de) * 2007-08-03 2009-02-05 Ab Skf Getriebelageranordnung mit wenigstens einem zweireihigen Schrägkugellager
EP3266448B1 (en) 2009-03-27 2022-02-16 Intervet International B.V. Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
AU2010254235B2 (en) 2009-05-26 2015-04-02 Advanced Bionutrition Corporation Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
BR112012018839B1 (pt) 2010-01-28 2020-04-14 Advanced Bionutrition Corp composição vítrea seca compreendendo um material bioativo
WO2012018638A2 (en) 2010-07-26 2012-02-09 Biomatrica, Inc. Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
WO2012018639A2 (en) 2010-07-26 2012-02-09 Biomatrica, Inc. Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
MX350047B (es) 2010-08-13 2017-08-24 Advanced Bionutrition Corp Composicion de estabilizacion de almacenamiento en seco para materiales biologicos.
CN114262690A (zh) 2011-04-15 2022-04-01 吉恩勒克斯公司 减毒的痘苗病毒的克隆毒株及其使用方法
US20140140959A1 (en) 2012-10-05 2014-05-22 Aladar A. Szalay Energy Absorbing-Based Diagnostic and Therapeutic Methods Employing Nucleic Acid Molecules Encoding Chromophore-Producing Enzymes
EP3249054A1 (en) 2012-12-20 2017-11-29 Biomatrica, INC. Formulations and methods for stabilizing pcr reagents
WO2015103438A2 (en) 2014-01-02 2015-07-09 Genelux Corporation Oncolytic virus adjunct therapy with agents that increase virus infectivity
WO2015191632A1 (en) 2014-06-10 2015-12-17 Biomatrica, Inc. Stabilization of thrombocytes at ambient temperatures
EP3328215B1 (en) 2015-07-29 2021-07-07 Advanced BioNutrition Corp. Stable dry probiotic compositions for special dietary uses
US12558395B2 (en) 2015-07-29 2026-02-24 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
KR102589056B1 (ko) 2015-12-08 2023-10-12 바이오매트리카 인코포레이티드 적혈구 침강 속도의 감소
CN105462840A (zh) * 2015-12-10 2016-04-06 浙江卫信生物药业有限公司 一种口腔支原体的活体冻干体的制备方法
CN120676952A (zh) 2022-07-08 2025-09-19 维罗米梭公司 溶瘤痘苗病毒及其重组病毒和使用方法
CN116585724A (zh) * 2023-05-25 2023-08-15 广州和实生物技术有限公司 玻璃化真空干燥试剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8801338D0 (en) * 1988-01-21 1988-02-17 Quadrant Bioresources Ltd Preservation of viruses
GB9125695D0 (en) * 1991-12-03 1992-01-29 Mastavac Limited Medical preparations
JP4502406B2 (ja) * 1995-06-07 2010-07-14 クアドラント、ドラッグ、デリバリー、リミテッド 乾燥発泡ガラスマトリックス内に物質を安定に配合する方法及びそれによって得られた組成物
US5766520A (en) * 1996-07-15 1998-06-16 Universal Preservation Technologies, Inc. Preservation by foam formation

Also Published As

Publication number Publication date
ES2290028T3 (es) 2008-02-16
DK1175486T3 (da) 2007-10-29
WO2000066710A3 (en) 2001-02-08
EP1175486B1 (en) 2007-07-11
KR20020012201A (ko) 2002-02-15
OA11936A (en) 2006-04-12
AP1521A (en) 2005-12-22
WO2000066710A2 (en) 2000-11-09
CN1433465A (zh) 2003-07-30
AU776982B2 (en) 2004-09-30
CA2365277A1 (en) 2000-11-09
TR200103149T2 (tr) 2002-01-21
DE60035497T2 (de) 2007-10-31
EA004131B1 (ru) 2003-12-25
KR100616195B1 (ko) 2006-08-25
ATE366797T1 (de) 2007-08-15
AU4584400A (en) 2000-11-17
EA200101167A1 (ru) 2002-06-27
EP1175486A2 (en) 2002-01-30
DE60035497D1 (de) 2007-08-23
AP2001002335A0 (en) 2001-12-31
JP2002542815A (ja) 2002-12-17
MXPA01011145A (es) 2003-07-14
US6664099B1 (en) 2003-12-16

Similar Documents

Publication Publication Date Title
AP1521A (en) Method for the preservation of viruses and mycoplasma.
BR0214822A (pt) Formulações contendo poxvìrus e processo para preparar composições contendo poxvìrus estáveis
NO20030411L (no) Farmasöytiske sammensetninger for behandlingen av smertefulle, inflammatoriske og ulceröse tilstander av fuktige epiteloverflater slik sommukositt, stomatitt og Behcets syndrom
DE60019902D1 (de) Echinocandin pharmazeutische zusammensetzungen
AR020717A1 (es) Proteinas terapeuticamente activas en plantas.
DK0693281T3 (da) Farmaceutiske fluoxetinformuleringer
DE69915458D1 (de) Dextran formulierungen zur behandlung entzündlicher gelenkerkrankungen
EP1385466A4 (en) ONCOLYTIC VIRUS THERAPY
BR0213213A (pt) composições farmacêuticas pró-micela
NO20026044D0 (no) Behandling av human papillomavirus
DE69836822D1 (de) Verfahren zur Behandlung von Kapseln und trockenen gepulverten pharmazeutischen Formulierungen
DE60013821D1 (de) Verfahren zur konservierung von biologisch aktivem material
BR9507846A (pt) Composição farmacéutica estável e fortemente concentrada de principio ativo da classe dos taxóides escolhido entre o docetaxol ou os derivados do docetaxol processo de preparação desta composição e utilização de uma solução congelada ou liofilizada
MD20020075A (en) Antimicrobial preparation with retarded release of the biologically active component, utilization thereof and process for implant obtaining
ES2185900T3 (es) Composicion farmacologica que comprende un componente p serico del amiloide para el tratamiento profilactico o terapeutico de infecciones viricas y un hit para la deteccion de union entre dicha composicion y componentes viricos.
BR9912218A (pt) Compostos obtidos de espécies de sálvia possuindo atividade antivirótica
BR0206995A (pt) Tratamento do vìrus da hepatite b
MX2023011087A (es) Composicion farmaceutica acuosa o composicion farmaceutica liofilizada estable.
FR2633518B1 (fr) Procede de stabilisation des vaccins et associations de vaccins a virus attenues conserves sous forme lyophilisee, et compositions obtenues
UY28282A1 (es) Mediadores peptidicos del trasporte inverso de colesterol para el tratamiento de hipercolesterolemia
BR9916893A (pt) Tratamento
MX9301922A (es) Composiciones para el tratamiento de infeccion y enfermedad ocasionadas por el virus de hepatitis b (hbv).
MX2025004270A (es) Formulacion de vacuna contra el dengue
ECSP003859A (es) Composicion para el tratamiento de tejidos dañados
RU96120655A (ru) Композиция для профилактики и лечения гриппа и орви

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: ANHYDRO LIMITED (GB)

Free format text: TRANSFERIDO DE: ERIC EDWARD WORRALL

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 13 E 24 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.